Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa : findings of the 2020–2021 population-based household survey

dc.contributor.authorMoyo, Sizulu
dc.contributor.authorSimbayi, Leickness C.
dc.contributor.authorZuma, Khangelani
dc.contributor.authorZungu, Nompumelelo Precious
dc.contributor.authorMarinda, Edmore
dc.contributor.authorJooste, Sean
dc.contributor.authorRamlagan, Shandir
dc.contributor.authorFortuin, Mirriam
dc.contributor.authorSingh, Beverley
dc.contributor.authorMabaso, Musawenkosi
dc.contributor.authorReddy, Tarylee
dc.contributor.authorParker, Whadi-ah
dc.contributor.authorNaidoo, Inbarani
dc.contributor.authorManda, S.O.M. (Samuel)
dc.contributor.authorGoga, Ameena Ebrahim
dc.contributor.authorNgandu, Nobubelo
dc.contributor.authorCawood, Cherie
dc.contributor.authorMoore, Penny L.
dc.contributor.authorPuren, Adrian
dc.date.accessioned2024-09-17T12:44:17Z
dc.date.available2024-09-17T12:44:17Z
dc.date.issued2023-09-25
dc.descriptionDATA AVAILABILITY STATEMENT : The data for this manuscript can be found at this link https:// hsrcacza-my.sharepoint.com/personal/sjooste_ hsrc_ac_za/_layouts/15/onedrive.aspx?id=% 2Fpersonal%2Fsjooste%5Fhsrc%5Fac%5Fza% 2FDocuments%2FNCAS%5FKey%5FData&ga=1.en_US
dc.description.abstractPopulation-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2 serosurvey in people 12 years and older in South Africa. This cross-sectional multi-stage random stratified cluster survey undertaken from November 2020 to June 2021 collected sociodemographic data, medical history, behavioural data, and blood samples from consenting participants. The samples were tested for SARS-CoV-2 antibodies using the Roche ElecsysAnti-SARS-CoV-2 chemiluminescence immunoassay (CLIA) Total Antibody Test. The survey data were weighted by age, race, sex, and province with final individual weights benchmarked against the 2020 mid-year population estimates and accounted for clustering. Descriptive statistics summarize the characteristics of participants and seroprevalence. Logistic regression analyses were used to identify factors associated with seropositivity. From 13290 survey participants (median age 33 years, interquartile range (IQR) 23–46 years), SARS-CoV-2 seroprevalence was 37.8% [95% Confidence Interval (CI) 35.4–40.4] and varied substantially across the country’s nine provinces, and by sex, age and locality type. In the final adjusted model, the odds of seropositivity were higher in women than in men [aOR = 1.3 (95% CI: 1.0–1.6), p = 0.027], and those living with HIV (self-report) [aOR = 1.6 (95% CI: 1.0–2.4), p = 0.031]. The odds were lower among those 50 years and older compared to adolescents 12–19 years old [aOR = 0.6 (95% CI: 0.5–0.8), p<0.001] and in those who did not attend events or gatherings [aOR = 0.7 (95% CI: 0.6–1.0), p = 0.020]. The findings help us understand the epidemiology of SARS-CoV-2 within different regions in a low-middle-income country. The survey highlights the higher risk of infection in women in South Africa likely driven by their home and workplace roles and also highlighted a need to actively target and include younger people in the COVID-19 response.en_US
dc.description.departmentPaediatrics and Child Healthen_US
dc.description.departmentPsychologyen_US
dc.description.librarianam2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipThe Solidarity Fund, South Africa, the Human Sciences Research Council, South Africa, and the National Institute for Communicable Diseases, South Africa.en_US
dc.description.urihttps://journals.plos.org/globalpublichealth/en_US
dc.identifier.citationMoyo, S., Simbayi, L.C., Zuma, K., Zungu, N., Marinda, E., Jooste, S., et al. (2023) Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey. PLoS Global Public Health 3(9): e0002358. https://DOI.org/10.1371/journal.pgph.0002358.en_US
dc.identifier.issn2767-3375 (online)
dc.identifier.other10.1371/journal.pgph.0002358
dc.identifier.urihttp://hdl.handle.net/2263/98280
dc.language.isoenen_US
dc.publisherPublic Library of Scienceen_US
dc.rights© 2023 Moyo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License.en_US
dc.subjectWomenen_US
dc.subjectInfectionen_US
dc.subjectCOVID-19 pandemicen_US
dc.subjectCoronavirus disease 2019 (COVID-19)en_US
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)en_US
dc.subjectSeroprevalence surveyen_US
dc.subjectSouth Africa (SA)en_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleSeroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa : findings of the 2020–2021 population-based household surveyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Moyo_Seroprevalence_2023.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: